Keep pace with the industry and learn more about the research behind medical breakthroughs and discoveries.
Sign up to receive updates
Remain in-the-know for all things iSpecimen. We'll send you news you won't want to miss.
Mar 28, 2022
Beauty and immunity: natural bedfellows
Looks do matter, at least when it comes to immune system performance, suggests a new study.
Mar 11, 2022
A case study in finding cost effective FFPE blocks
Some of the best values are hidden in plain sight, like Toyotas, index funds and refurbished electronics. The same is true in the biospecimen world. Let us walk you through it. We’re known by many clients for giving researchers access to millions of banked and clinical remnant samples through our online platform, the iSpecimen Marketplace,…
Mar 10, 2022
Soon, perhaps, a blood test for long COVID
Why do roughly 1 in 3 COVID-19 patients experience symptoms lasting a month or more? And which newly diagnosed patients will develop so-called “long COVID”? Researchers may be approaching answers with the discovery that reduced levels of certain antibodies in the blood may help predict who will suffer long COVID.
Jan 18, 2022
iSpecimen expands fight against covid-19
As the pandemic continues to rear its ugly head this winter, we have strengthened our fight against the disease by expanding our supplier network with the addition of a new reference lab in New York to support commercial and government customers focused on COVID-19 research involving the Omicron and Delta variants. The reference lab has…
Oct 07, 2021
AI-assisted liquid biopsy shows results on lung cancer
Lung cancer is a leading cause of cancer death, making up nearly 25% of all cancer deaths (not all of which are smoking-related), but only 5% to 6% of at-risk Americans undergo recommended CT screening, with many concerned about radiation exposure and invasive procedures.
Sep 09, 2021
Getting to the bottom of IBS
Irritable bowel syndrome (or IBS), characterized by stomach pain, bloating, cramping, constipation and diarrhea, is diagnosed in an estimated 1.3% of U.S. adults. In a country of 330 million, that’s a lot.
Sep 02, 2021
This cancer test is personal
We’re seeing encouraging progress in cancer diagnostics with news of positive results from an innovative blood test to detect circulating tumor DNA.
May 20, 2021
How precision medicine will come together in the next decade
Innovators have bestowed upon the world powerful tools for advancing precision medicine – including genomic sequencing, electronic health records, artificial intelligence, and wearables – but how do we put them to work?
Dec 18, 2020
With iSpecimen’s support, researchers drive growing market for regenerative medicine
Harvard scientists reported earlier this month that they essentially cured blindness in lab mice by delivering youth-restoring genes into the animals’ retinas, thus “turning back the clock” on their cells. The achievement perfectly parallels the breakthroughs medical researchers are pursuing for humans in the field of regenerative medicine – the repair, rejuvenation and replacement of diseased or damaged tissues and organs.